Changing health environment: The challenge to demonstrate cost-effectiveness of new compounds Bengt Jönsson Review Article 23 September 2012 Pages: 5 - 10
The burden of coronary, cerebrovascular and peripheral arterial disease Ameet Bakhai Review Article 23 September 2012 Pages: 11 - 18
The value of clopidogrel versus aspirin in reducing atherothrombotic events: The CAPRIE study Isabelle Durand-ZaleskiMichel Bertrand Review Article 23 September 2012 Pages: 19 - 27
The value of clopidogrel in addition to standard therapy in reducing atherothrombotic events William S. WeintraubBengt JönssonMichel Bertrand Review Article 23 September 2012 Pages: 29 - 41